Rotigotine CAS : 99795-59-6 GMP DMF
Name : Rotigotine
CAS No . : 99795-59-6
Chemical Name : (S)-6-[Propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol
Molecular Formula : C19H25NOS
Molecular Weight : 315.48
Description: Rotigotine is the active pharmaceutical ingredient (API) of
branded drug Neupro. The developing history of Rotigotine is quite
long. It was developed in 1985 by University of Groningen. Aderis
Pharmaceuticals continued its development. A German company called
Schwarz Pharma (now a subsidiary of UCB S.A.) got worldwide
development and commercialization rights from Aderis in 1998.
Rotigotine is used to treat Parkinson’s disease (PD) and restless
legs syndrome (RLS). Rogitine is maybe also useful to treat
depression. Rogotine (Neupro) was approved by EMEA in Europe in
2006 and by FDA in USA in 2007.
The drug might be protected by patents in some courtires or areas.
We only sell it to non patent protected countries or areas. The
sale to patent protection countries and areas is only for R & D
purpose. The buyers should take all responsiblity of patent status
in his countries or areas.
Competitive Advantage: Produced under cGMP conditions, support